CLINICAL_TRIALS
trial_result
· 2023-05-11
Clinical Trial Update: 68Ga-NY104 PET/CT in Von Hippel-Lindau Disease [Phase 2]
Summary
Phase 2 clinical trial update on 68Ga-NY104 PET/CT imaging for Von Hippel-Lindau disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Von Hippel-Lindau Disease | Phase 2 | Status: UNKNOWN